Ligand validation:1AEO

2AP: 2-AMINOPYRIDINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1AEO_2AP_A_296	64%	0%	0.075	0.87	1.06	7.67	-	4	0	0	100%	1
5MNB_2AP_A_304	89%	16%	0.074	0.957	1.56	1.99	1	2	0	0	100%	1
5MN1_2AP_A_306	86%	17%	0.081	0.955	1.58	1.92	1	1	0	0	100%	1
6DUC_2AP_B_403	43%	1%	0.116	0.836	2.38	4.97	1	5	0	0	100%	1
7PYC_2AP_A_801	33%	2%	0.15	0.829	1.83	4.43	2	4	2	0	100%	1
3RXC_2AP_A_9	31%	1%	0.138	0.807	1.24	5.71	1	5	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.